SurModics Inc. (SRDX) Enters Ophthalmic License and Development Agreement with Roche (RHHBY) (JOBS) and Genentech (South SF) (DNA) (JOBS); SurModics Could Receive Up to Approximately $200 Million
10/6/2009 6:31:37 AM
More...
|
Genentech, Inc. (DNA) Release: Xeloda(R)-Oxaliplatin Combination (XELOX) Shown to Be More Effective Than Standard Chemotherapy Regimen in Adjuvant Colon Cancer
7/20/2009 10:16:14 AM
More...
|
New Data from OSI Pharmaceuticals, Inc. (OSIP) (JOBS), Genentech, Inc. (Oceanside) (DNA) (JOBS) Phase III SATURN Study Showed Tarceva Improved Overall Survival When Used Immediately After Initial Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
7/13/2009 6:32:20 AM
More...
|
Genentech, Inc. (DNA): Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retinal Vein Occlusion
7/6/2009 9:46:53 AM
More...
|
Facebook Taps Ex-Genentech, Inc. (Oceanside) (DNA) CFO for Finance Chief
6/30/2009 8:44:30 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech, Inc. (DNA)
6/29/2009 8:49:25 AM
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Announces Conclusion of Arbitration with Genentech, Inc. (DNA)
6/17/2009 7:46:09 AM
More...
|
Bayhill Therapeutics, Inc. Enters Exclusive, Worldwide Collaboration with Genentech, Inc. (DNA) (JOBS) for BHT-3021 in Type 1 Diabetes; Deal Could Potentially Exceed $350M
6/10/2009 7:22:53 AM
More...
|
Genentech, Inc. (DNA) Release: Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival in Advanced Breast Cancer
5/29/2009 8:32:36 AM
More...
|
Genentech, Inc. (DNA) And Biogen Idec, Inc. (California) (BIIB) Submit Applications to the FDA for Rituxan for Most Common Type of Adult Leukemia
5/20/2009 9:25:21 AM
More...
|
|